EBS Technologies is a MedTech company based in Potsdam, Germany. The company has developed a stimulation system for the treatment of neurologically caused impairments such as visual field loss. The EBS Therapy is a non-invasive optic nerve stimulation deploying weak electrical currents, resulting in neuroregeneration and neuroprotection. This startup showcase will explore the technology behind EBS Therapy and the company’s journey to bring this innovative treatment to patients.
The EBS Therapy
EBS Therapy is a non-invasive treatment that uses electrical stimulation to activate the optic nerve. The therapy is designed to help patients suffering from neurologically caused impairments such as visual field loss, which can be the result of stroke, traumatic brain injury, glaucoma or several other diseases. The therapy deploys weak electrical currents that are administered at frequencies and amplitudes identified as optimal for each patient. These electrical currents allow retinal ganglion cells to regenerate and branch out new axons. The therapy aims to restore vision and improve the quality of life for patients.
Research and Clinical Experience
EBS Technologies benefits from more than 15 years of research and clinical experience with more than 1,200 patients. The company has conducted double-blind, randomized studies, as well as clinical observations to test the efficacy of the EBS Therapy. The studies show that the therapy can partially restore vision field in patients, making it a promising option for people suffering from visual impairments.
Receiving the CE Mark and Starting Commercial Treatment
In 2013, EBS Technologies received the CE Mark for the stimulation device and started the commercial treatment in 2014. The company has since established 8 EBS Treatment centers across Germany and is slowly widening the network. The EBS Therapy has gained popularity among patients and healthcare providers due to its non-invasive nature and promising results. The therapy offers a new treatment option for patients with neurologically caused impairments and has the potential to improve their quality of life.
Conclusion
EBS Technologies is a MedTech company that has developed a stimulation system for the treatment of neurologically caused impairments such as visual field loss. The EBS Therapy is a non-invasive optic nerve stimulation deploying weak electrical currents, resulting in neuroregeneration and neuroprotection. The company benefits from more than 15 years of research and clinical experience with more than 1,200 patients, and has conducted double-blind, randomized studies, as well as clinical observations to test the efficacy of the therapy. The EBS Therapy has gained popularity among patients and healthcare providers and offers a new treatment option for patients with neurologically caused impairments. EBS Technologies is an example of a MedTech startup that has leveraged innovative technology to develop a therapy that has the potential to improve the lives of patients.
Website: http://www.ebstech.de
Facebook: https://www.facebook.com/EBS-Technologies-GmbH-1631686487093923/
LinkedIn: https://www.linkedin.com/company/3847516?trk=prof-exp-company-name
Want to amplify your startup’s story? EU Startup News is your launchpad to reach startup founders, investors, and C-level execs across Europe. Discover our tailored promotional strategies such as Sponsored Articles and Partnerships. Click here to learn more or contact us directly at [email protected]. Join us, and let’s make your startup the talk of Europe!
